Doctor profile · Federal record
Dr. Mark Jaffe, MD
Dermatology Physician (CMS: Dermatology) · Bethesda, MD
- NPI 1629089107
- Accepts Medicare
- MIPS 100.0 / 100 · 2023
- 47 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
6410 Rockledge Drive, Suite 402
Bethesda, MD 20817
(301) 530-4800
fax (301) 530-1847
Credentials & registration
- NPI registered
- August 2006 — 20 yrs on file
- Profile last updated
- March 27, 2008
- Year of graduation
- 1979 — 47 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Maryland #D25894
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1629089107. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
5,272
Distinct HCPCS
10
Medicare allowed
$370,472
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 1,317 | 876 | $103 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 1,234 | 283 | $8 | |
17000 |
Destruction of precancer skin growth, 1 growth | 647 | 425 | $63 | |
17110 |
Destruction of skin growth, 1-14 growths | 527 | 417 | $126 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 309 | 98 | $1 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 211 | 161 | $65 | |
11900 |
Injection into skin growth, 1-7 growths | 168 | 93 | $55 | |
96372 |
Injection of drug or substance under skin or into muscle | 139 | 39 | $16 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 105 | 85 | $144 | |
J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 103 | 20 | $2 |
In context: peer comparison
Among 10 peers in Bethesda Dermatology Physician, average services per provider: 158. This provider delivers 33× the peer median.Open Payments
Industry payments received
All-time total
$1,827
Transactions
64
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Hill Dermaceuticals, INC. | 1 | $308.76 | |
| Genzyme Corporation | 5 | $211.05 | |
| Abbvie INC. | 8 | $151.43 | |
| Arcutis Biotherapeutics, INC. | 8 | $132.22 | |
| Sun Pharmaceutical Industries INC. | 6 | $120.37 | |
| Incyte Corporation | 5 | $106.00 | |
| Amgen INC. | 4 | $94.92 | |
| Galderma Laboratories, L.P. | 5 | $86.95 | |
| Verrica Pharmaceuticals INC. | 4 | $77.51 | |
| Dermavant Sciences, INC. | 3 | $72.56 | |
| Leo Pharma INC. | 3 | $70.69 | |
| Janssen Biotech, INC. | 3 | $68.26 | |
| Pfizer INC. | 3 | $68.12 | |
| E.R. Squibb & Sons, L.L.C. | 3 | $61.53 | |
| Lilly USA, LLC | 3 | $59.83 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
682
Patients
414
Total drug cost
$21,439
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Betamethasone Dipropionate | Generic | 112 | 68 | $4,781 |
| Triamcinolone Acetonide | Generic | 78 | 51 | $1,068 |
| Mometasone Furoate | Generic | 68 | 50 | $1,785 |
| Hydrocortisone | Generic | 60 | 37 | $666 |
| Minoxidil | Generic | 46 | 17 | $619 |
| Ketoconazole | Generic | 44 | 25 | $1,024 |
| Mupirocin | Generic | 37 | 30 | $424 |
| Metronidazole | Generic | 35 | 19 | $3,737 |
| Alclometasone Dipropionate | Generic | 34 | 21 | $1,756 |
| Fluconazole | Generic | 33 | 12 | $400 |
Frequently asked questions
What is Dr. Mark Jaffe's medical specialty?
Dr. Mark Jaffe practices Dermatology Physician in Bethesda, MD.
Where does Dr. Mark Jaffe practice?
Dr. Mark Jaffe practices at 6410 Rockledge Drive, Bethesda, MD 20817. Office phone: 3015304800.
What is Dr. Mark Jaffe's NPI?
Dr. Mark Jaffe's National Provider Identifier (NPI) is 1629089107, issued by NPPES.
Does Dr. Mark Jaffe accept Medicare assignment?
Yes. Dr. Mark Jaffe accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mark Jaffe commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.